Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
Provided are methods for preparing sterilized, gelled, solubilized extracellular matrix (ECM) compositions useful as cell growth substrates. Also provided are compositions prepared according to the methods as well as uses for the compositions. In one embodiment a device, such as a prosthesis, is provided which comprises an inorganic matrix into which the gelled, solubilized ECM is dispersed to facilitate in-growth of cells into the ECM and thus adaptation and/or attachment of the device to a patient.
1. A gelable extracellular matrix (ECM) composition comprising a decellularized, enzymatically digested, dried, electron-beam sterilized, intact extracellular matrix, wherein said composition is capable of forming a gel upon hydration, neutralization to pH 7.2-7.8, and warming to a temperature greater than 25° C.
2. The composition of claim 1 , wherein the composition comprises a protease.
3. The composition of claim 2 , wherein the protease is pepsin or trypsin.
4. The composition of claim 1 , wherein the extracellular matrix is bioactive.
5. The composition of claim 1 , wherein the extracellular matrix is derived from urinary bladder, spleen, liver, heart, pancreas, ovary, small intestine, large intestine, colon, esophagus, central nervous system tissue, adipose tissue, dermis, or bone.
6. The composition of claim 1 , wherein the extracellular matrix is from a human, monkey, pig, cow, or sheep.
7. The composition of claim 1 , wherein said composition is capable of forming a gel when warmed to 37° C.
8. A biocompatible scaffold coated with the composition according to claim 1 .
9. The biocompatible scaffold of claim 8 , wherein the scaffold comprises: (a) one or more of a cobalt-chrome alloy, stainless steel, titanium, tantalum, and a titanium alloy; (b) an inorganic mineral; (c) a ceramic; and/or (d) a polymer.
10. A method of preparing an extracellular matrix-derived gelable composition comprising, in order: (i) solubilizing intact extracellular matrix (ECM) by digestion with an acid protease in an acidic solution to produce a digest solution; (ii) drying the digest solution; and (iii) terminally sterilizing the dried digest with electron beam radiation.
11. The method of claim 10 , further comprising: (iv) hydrating and neutralizing the sterilized, dried digest to a pH between 7.2 and 7.8 to produce a neutralized digest solution; and (v) gelling the solution at a temperature greater than 25° C.
12. The method of claim 11 , wherein the neutralized digest solution is maintained at or below 25° C. before gelation.
13. The method of claim 11 , further comprising coating a matrix of a biocompatible scaffold with the solubilized ECM and gelling the matrix.
14. The method of claim 13 , wherein the biocompatible scaffold comprises: (a) one or more of a cobalt-chrome alloy, stainless steel, titanium, tantalum, and a titanium alloy; (b) an inorganic mineral; (c) a ceramic; and/or (d) a polymer.
15. The method of claim 10 , wherein the ECM is not terminally sterilized, dialyzed, or subjected to a cross-linking process prior to the solubilizing step.
16. The method of claim 10 , wherein the digest solution is lyophilized.
17. The method of claim 10 , wherein the ECM is derived from mammalian tissue.
18. The method of claim 17 , wherein the mammalian tissue is derived from one of urinary bladder, spleen, liver, heart, central nervous system tissue, adipose tissue, bone, pancreas, ovary, small intestine, large intestine, or colon.
19. The method of claim 10 , wherein the ECM is comminuted.
20. The method of claim 10 , wherein the acid protease is pepsin.